US Stock MarketDetailed Quotes

Apogee Therapeutics (APGE)

Watchlist
  • 83.030
  • +1.220+1.49%
Close May 8 16:00 ET
  • 83.030
  • 0.0000.00%
Post 16:10 ET
5.14BMarket Cap-19.68P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apogee Therapeutics (APGE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
31.69%285.6M
2.87%78.06M
21.46%71.28M
65.82%73.17M
65.25%63.1M
133.19%216.87M
104.23%75.88M
141.46%58.69M
133.64%44.12M
201.64%38.18M
Selling and administrative expenses
42.34%69.75M
23.19%19.28M
29.27%16.77M
56.99%17.14M
75.02%16.57M
99.38%49.01M
90.85%15.65M
79.27%12.97M
121.02%10.92M
125.20%9.47M
-General and administrative expense
42.34%69.75M
23.19%19.28M
29.27%16.77M
56.99%17.14M
75.02%16.57M
99.38%49.01M
90.85%15.65M
79.27%12.97M
121.02%10.92M
125.20%9.47M
Research and development costs
27.91%214.71M
-2.96%58.44M
18.52%54.18M
67.75%55.7M
61.54%46.39M
145.33%167.87M
108.02%60.23M
167.82%45.71M
138.10%33.21M
239.63%28.72M
Depreciation amortization depletion
--1.13M
--331K
--331K
--325K
--143K
--0
--0
--0
--0
--0
-Depreciation and amortization
--1.13M
--331K
--331K
--325K
--143K
--0
--0
--0
--0
--0
Operating profit
-31.69%-285.6M
-2.87%-78.06M
-21.46%-71.28M
-65.82%-73.17M
-65.25%-63.1M
-133.19%-216.87M
-104.23%-75.88M
-141.46%-58.69M
-133.64%-44.12M
-201.64%-38.18M
Net non-operating interest income expense
-13.56%30.03M
0.58%8.73M
-34.65%6.32M
-30.71%7.14M
28.80%7.84M
285.25%34.74M
60.17%8.68M
179.02%9.67M
10.31M
4,476.69%6.09M
Non-operating interest income
-13.56%30.03M
0.58%8.73M
-34.65%6.32M
-30.71%7.14M
28.80%7.84M
285.25%34.74M
60.17%8.68M
179.02%9.67M
--10.31M
4,476.69%6.09M
Other net income (expense)
Income before tax
-40.32%-255.57M
-3.16%-69.33M
-32.52%-64.96M
-95.24%-66.02M
-72.17%-55.26M
-116.86%-182.13M
-111.75%-67.2M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
Income tax
1,444.44%278K
244.44%62K
61K
72K
83K
18K
18K
0
0
0
Net income
-40.46%-255.84M
-3.23%-69.39M
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
Net income continuous Operations
-40.46%-255.84M
-3.23%-69.39M
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
Minority interest income
Net income attributable to the parent company
-40.46%-255.84M
-3.23%-69.39M
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.46%-255.84M
-3.23%-69.39M
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
Basic earnings per share
-27.88%-4.22
13.45%-1.03
-29.07%-1.11
-88.33%-1.13
-48.44%-0.95
1.79%-3.3
-81.94%-1.19
-68.63%-0.86
-51.28%-0.6
-39.23%-0.64
Diluted earnings per share
-27.88%-4.22
13.45%-1.03
-29.07%-1.11
-88.33%-1.13
-48.44%-0.95
1.79%-3.3
-81.94%-1.19
-68.63%-0.86
-51.28%-0.6
-39.23%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 31.69%285.6M2.87%78.06M21.46%71.28M65.82%73.17M65.25%63.1M133.19%216.87M104.23%75.88M141.46%58.69M133.64%44.12M201.64%38.18M
Selling and administrative expenses 42.34%69.75M23.19%19.28M29.27%16.77M56.99%17.14M75.02%16.57M99.38%49.01M90.85%15.65M79.27%12.97M121.02%10.92M125.20%9.47M
-General and administrative expense 42.34%69.75M23.19%19.28M29.27%16.77M56.99%17.14M75.02%16.57M99.38%49.01M90.85%15.65M79.27%12.97M121.02%10.92M125.20%9.47M
Research and development costs 27.91%214.71M-2.96%58.44M18.52%54.18M67.75%55.7M61.54%46.39M145.33%167.87M108.02%60.23M167.82%45.71M138.10%33.21M239.63%28.72M
Depreciation amortization depletion --1.13M--331K--331K--325K--143K--0--0--0--0--0
-Depreciation and amortization --1.13M--331K--331K--325K--143K--0--0--0--0--0
Operating profit -31.69%-285.6M-2.87%-78.06M-21.46%-71.28M-65.82%-73.17M-65.25%-63.1M-133.19%-216.87M-104.23%-75.88M-141.46%-58.69M-133.64%-44.12M-201.64%-38.18M
Net non-operating interest income expense -13.56%30.03M0.58%8.73M-34.65%6.32M-30.71%7.14M28.80%7.84M285.25%34.74M60.17%8.68M179.02%9.67M10.31M4,476.69%6.09M
Non-operating interest income -13.56%30.03M0.58%8.73M-34.65%6.32M-30.71%7.14M28.80%7.84M285.25%34.74M60.17%8.68M179.02%9.67M--10.31M4,476.69%6.09M
Other net income (expense)
Income before tax -40.32%-255.57M-3.16%-69.33M-32.52%-64.96M-95.24%-66.02M-72.17%-55.26M-116.86%-182.13M-111.75%-67.2M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M
Income tax 1,444.44%278K244.44%62K61K72K83K18K18K000
Net income -40.46%-255.84M-3.23%-69.39M-32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M
Net income continuous Operations -40.46%-255.84M-3.23%-69.39M-32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M
Minority interest income
Net income attributable to the parent company -40.46%-255.84M-3.23%-69.39M-32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.46%-255.84M-3.23%-69.39M-32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M-156.24%-32.09M
Basic earnings per share -27.88%-4.2213.45%-1.03-29.07%-1.11-88.33%-1.13-48.44%-0.951.79%-3.3-81.94%-1.19-68.63%-0.86-51.28%-0.6-39.23%-0.64
Diluted earnings per share -27.88%-4.2213.45%-1.03-29.07%-1.11-88.33%-1.13-48.44%-0.951.79%-3.3-81.94%-1.19-68.63%-0.86-51.28%-0.6-39.23%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +12.40%
Sample Name
Sample Code
 +11.01%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.22%
5
United States Oil Fund LP
USO
+7.03%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.20%
Sample Name
Sample Code
 +18.16%
Sample Name
Sample Code
 +12.05%
4
KE Holdings
BEKE
+10.61%
5
ASE Technology
ASX
+8.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -